SCHEMBL3300217

SCHEMBL3300217

COc1ccc(C(C)(C)C)c([SiH](O[SiH](c2cc(OC)ccc2C(C)(C)C)c2cc(OC)ccc2C(C)(C)C)c2cc(OC)ccc2C(C)(C)C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
ALDH1A1 P00352 5/20 0.40
GAA P10253 2/20 0.40
CA12 O43570 2/20 0.36
CA7 P43166 2/20 0.36
CA9 Q16790 2/20 0.36
CA14 Q9ULX7 2/20 0.36
CYP1A2 P05177 5/20 0.36
CYP1A1 P04798 3/20 0.36
CYP1B1 Q16678 3/20 0.36
LPAR1 Q92633 1/20 0.35
CYP2A6 P11509 1/20 0.35
KDM4E B2RXH2 3/20 0.35
MEN1 O00255 2/20 0.35
LMNA P02545 2/20 0.35
POLB P06746 2/20 0.35
KMT2A Q03164 2/20 0.35
NPC1 O15118 1/20 0.35
NQO2 P16083 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3296284 0.87 CA1 (0.47) CA1CA2ALDH1A1GAACA12
SCHEMBL3297740 0.81 NQO1 (0.42) CA1ALDH1A1CA12CA7CA9
SCHEMBL3301766 0.78 LTA4H (0.40) CA1CA2ALDH1A1GAACA12
SCHEMBL3296168 0.77 ALDH1A1 (0.38) CA1CA2ALDH1A1GAACA9
SCHEMBL3293251 0.76 CA12 (0.58) CA1CA2ALDH1A1CA12CA7
SCHEMBL3302633 0.76 CA2 (0.35) CA1CA2ALDH1A1CYP1A2KDM4E
SCHEMBL10320491 0.76 CA1 (0.56) CA1CA2ALDH1A1GAACA12
SCHEMBL3295199 0.75 CA12 (0.40) CA1CA2ALDH1A1GAACA12
SCHEMBL3229459 0.74 CA1 (0.48) CA1CA2ALDH1A1GAACA12
SCHEMBL14502703 0.72 CA1 (0.47) CA1CA2ALDH1A1GAACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741393-B2 Organic silicon-based compound and method of producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-22 US disclosed
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same SUMITOMO CHEMICAL COMPANY, LIMITED 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same ARSA, OR10J3, HDAC10 CA1 2428/4885CA2 3413/4885ALDH1A1 1865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.